Citation Impact
Citing Papers
Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies
2003
Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel Blockers
2008
Body Size and Ethnicity Are Associated with Menstrual Cycle Alterations in Women in the Early Menopausal Transition: The Study of Women’s Health across the Nation (SWAN) Daily Hormone Study
2004
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
HMG-CoA reductase inhibitors
2001
Ghrelin?a hormone with multiple functions
2004
The metabolic syndrome
2006
The metabolic syndrome
2010 Standout
Physical Performance Measures in the Clinical Setting
2003 Standout
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
2007
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Effect of dietary intervention and lipid-lowering treatment on brachial vasoreactivity in patients with ischemic heart disease and hypercholesterolemia
2003
Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid
2003
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Treatment Targets in the Management of Dyslipidemias: Which Targets in Whom?
2012
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
2019
Early statin therapy restores endothelial function in children with familial hypercholesterolemia
2002
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
2015 Standout
Linking C-Reactive Protein to Late-Life Disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002
2006
Non‐High‐Density Lipoprotein Cholesterol: An Alternate Target for Lipid‐Lowering Therapy
2004
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Atherosclerosis
2019 Standout
Lower Extremity Performance in Nondisabled Older Persons as a Predictor of Subsequent Hospitalization
2000
Prognostic Value of Usual Gait Speed in Well‐Functioning Older People—Results from the Health, Aging and Body Composition Study
2005 Standout
Type 2 diabetes mellitus
2015 Standout
Effects of Growth Hormone and Its Secretagogues on Bone
2001
Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index
2004 Standout
Lower Extremity Function and Subsequent Disability: Consistency Across Studies, Predictive Models, and Value of Gait Speed Alone Compared With the Short Physical Performance Battery
2000 Standout
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
2003
Ghrelin: Structure and Function
2005 Standout
The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
2014 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Effect Of Anti‐Oxidant Treatment And Cholesterol Lowering On Resting Arterial Tone, Metabolic Vasodilation And Endothelial Function In The Human Forearm: A Randomized, Placebo‐Controlled Study
2001
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
2006 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Gait Speed and Survival in Older Adults
2011 Standout
Muscle Power of the Ankle Flexors Predicts Functional Performance in Community‐Dwelling Older Women
2001
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
High-dose dexamethasone for prevention of cis-platin-induced vomiting
1981
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite
2004 Standout
The Control of Chemotherapy-Induced Emesis
1981
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors
2006 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
2005
Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering
2001
Mechanisms of Plaque Formation and Rupture
2014 Standout
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis
2004
Vision assessment using the NIH Toolbox
2013 Standout
Novel Agents for the Treatment of Type 2 Diabetes
2014
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
2005
The Pharmacology and Clinical Effectiveness of Phenothiazines and Related Drugs for Managing Chemotherapy-induced Emesis
1983
Influence of Low High-Density Lipoprotein Cholesterol and Elevated Triglyceride on Coronary Heart Disease Events and Response to Simvastatin Therapy in 4S
2001
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
2005
The Metabolic Syndrome
2008 Standout
Statin Therapy Accelerates Reendothelialization
2002
Endothelial Progenitor Cells
2004 Standout
High-Density Lipoprotein Cholesterol and the Role of Statins.
2002
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
2005
11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects
2013
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Oxidative stress‐related increase in ubiquitination in early coronary atherogenesis
2003 StandoutNobel
Sarcopenia: European consensus on definition and diagnosis
2010 Standout
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
2004
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
Reference Values for the Five-Repetition Sit-to-Stand Test: A Descriptive Meta-Analysis of Data from Elders
2006
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
Cisplatin
1984 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of D. Plotkin being referenced
Efficacy and safety of ezetimibe co‐administered with simvastatin in thiazolidinedione‐treated type 2 diabetic patients
2004
Lowering Low Density Lipoprotein Cholesterol with Simvastatin, a Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Does Not Affect Luteal Function in Premenopausal Women
2002
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial
2004
Are Performance-Based Measures Sufficiently Reliable for Use in Multicenter Trials?
1999
Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia
2003
Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia
2000
Effects of an 11 β ‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome
2011
Haloperidol in the treatment of nausea and vomiting due to cytotoxic drug administration.
1973
Effect of Cholesterol-Lowering Therapy on Coronary Endothelial Vasomotor Function in Patients With Coronary Artery Disease
2000
Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults
1999